FundedIQ
Biotechnology

PMV Pharmaceuticals: Funding, Investors & Team (Oct 2026)

PMV Pharma is developing first-in-class p53 and p53 pathway modulators for the treatment of cancer. Bringing together leaders in the field to utilize over three decades of p53 biology, PMV Pharma combines unique biological understanding with pharmaceutical development focus.

www.pmvpharma.com LinkedIn Redwood City, United States 11-50 employees
Biopharma Biotechnology Health Care Medical Device
Total raised
$70.0M
Rounds
1
Latest
Undisclosed round
Aug 2020

PMV Pharmaceuticals has raised $70.0M across 1 funding round on record, the most recent an undisclosed round of $70.0M announced in Aug 2020.

That round is above the $8.1M median round size for Biotechnology companies tracked on FundedIQ over the last two years.

PMV Pharmaceuticals Company Profile and Key Stats

Total funding raised
$70.0M
across 1 round on record
Funding rounds on record
1
Latest funding round
Undisclosed round
$70.0M in Aug 2020
Employees
11-50
reported band
Headquarters
Redwood City, United States

Latest funding round on record: Aug 2020.

PMV Pharmaceuticals Funding Rounds

Date
Round
Amount
Undisclosed round
$70.0M

PMV Pharmaceuticals Founders and Leadership Team

Name
Role
Contact
David Mack
CEO
Locked

Contact details for the PMV Pharmaceuticals team: 1 of 1 has an email address on file.

Start 14-day free trial →

PMV Pharmaceuticals Funding Compared to Other Biotechnology Startups

Segment
Companies
Median round
4,185
$8.1M
30,234
$7.6M

PMV Pharmaceuticals' latest round of $70.0M is above the median round in Biotechnology. Medians cover the last 24 months of disclosed rounds.

Funded Startups Like PMV Pharmaceuticals in Biotechnology and Redwood City

Companies Similar to PMV Pharmaceuticals

Series B $150M

Kallyope, we believe that the gut is the gateway to our internal world. Containing millions of neurons, the…

Undisclosed round $94.0M

Astrocyte Pharmaceuticals is a drug development company that helps in the recovery and well-being of brain…

Series B $9.5M

Tiny Health offers a gut health test specifically designed for mothers and babies aged 0 to 3 years.…

Series B $33.0M

Junevity is dedicated to using cutting-edge transcription factor medicines to combat age-related diseases.…

Undisclosed round —

Arkea Bio creates technology aimed at reducing greenhouse gas (GHG) emissions in the agricultural sector.

Series A $15.0M

Serán is a contract development and manufacturing organization providing a comprehensive suite of…

Private Equity —

Precision’s goal is to provide breakthrough treatments for the one billion patients worldwide suffering from…

Series D $250M

Enveda is a biotechnology company that utilizes AI-powered tools to explore and characterize molecules from…

Series E $311M

Avery Therapeutics, Inc. is a company dedicated to developing tissue engineered therapeutics to treat…

Undisclosed round $8.5M

Circle Pharma is a biotechnology company in the initial stages of development that uses unique computational…

Series E $92.5M

Evvy is for people with vaginas who want to be empowered with information about their microbiome. Their…

Series B $40.0M

PMV Pharmaceuticals Funding FAQs

What does PMV Pharmaceuticals do?

PMV Pharma is developing first-in-class p53 and p53 pathway modulators for the treatment of cancer. Bringing together leaders in the field to utilize over three decades of p53 biology, PMV Pharma combines unique biological understanding with pharmaceutical development focus.

How much funding has PMV Pharmaceuticals raised?

PMV Pharmaceuticals has raised $70.0M across 1 round on record. The most recent is an undisclosed round of $70.0M announced in Aug 2020.

When did PMV Pharmaceuticals last raise funding?

PMV Pharmaceuticals' most recent funding round on record is an undisclosed round of $70.0M, announced in Aug 2020.

Who is the CEO of PMV Pharmaceuticals?

David Mack is listed as CEO at PMV Pharmaceuticals.

Where is PMV Pharmaceuticals headquartered?

PMV Pharmaceuticals is based in Redwood City, California, United States.

How many employees does PMV Pharmaceuticals have?

PMV Pharmaceuticals is in the 11-50 employee band.

How does PMV Pharmaceuticals' funding compare to other Biotechnology startups?

PMV Pharmaceuticals' latest round of $70.0M is above the $8.1M median round size for Biotechnology companies on FundedIQ across 4,185 tracked companies over the last two years.

About FundedIQ's PMV Pharmaceuticals Funding Data

FundedIQ tracks announced funding rounds and refreshes this profile every week. Round dates, stages and amounts are normalised to a single format, converted to US dollars, and de-duplicated: two records of the same round announced days apart are merged, and two genuinely different rounds are kept apart on the amounts they disclose. Amounts shown are the disclosed figures only — a round announced without a number is listed and excluded from the total rather than estimated.

Employee counts are reported bands, not exact headcounts. Founder and executive names carry the job title on record. Anything we do not hold for PMV Pharmaceuticals is left off this page rather than filled in.

14-day free trial · Cancel anytime

Know who just raised. Then know who to reach.

Startup funding intelligence on every funded startup: the round, the investors and the founders, as a file in your inbox or searchable in the app.

Radar from $49/mo · Pro from $149/mo. Card required, nothing charged until day 15, and we email you 3 days before that. Need something specific? Custom plans from $499/mo.